Regeneron Announces EYLEA™ (aflibercept Ophthalmic Solution) Receives Unanimous Recommendation For Approval For Treatment Of Wet AMD From FDA

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that the Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S...

Full Story →